Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival

Background: The outlook for patients with esophageal and gastric (EG) cancer remains poor. Hence, there is a compelling need to identify novel treatment strategies and complementary biomarkers. Programmed death ligand 1 (PD-L1) and mismatch repair deficiency (dMMR) are putative biomarkers of respons...

Descripció completa

Dades bibliogràfiques

Autors principals:	Maria C. Svensson, David Borg, Cheng Zhang, Charlotta Hedner, Björn Nodin, Mathias Uhlén, Adil Mardinoglu, Karin Leandersson, Karin Jirström
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2019-03-01
Col·lecció:	Frontiers in Oncology
Matèries:	PD-L1 PD-1 MMR status MSI status esophageal cancer gastric cancer
Accés en línia:	https://www.frontiersin.org/article/10.3389/fonc.2019.00136/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!